Nick Woolf

Nick Woolf is an accomplished biotechnology professional with over 25 years of experience in the investment banking and life sciences industry in Australia and internationally. He has a strong track record in structuring, negotiating and executing successful alliances, licensing agreements and M&A transactions as well as providing business development, management and strategic leadership to organisations.

Mr Woolf is also a qualified accountant, a Graduate of the Australian Institute of Company Directors, holds a Graduate Certificate in Management (with Distinction ) from the Australian Institute of Business, and has a BA (Honours) and MA in Chemistry from Oxford University.

Lists and Charts

Revenue

Rank	Company	#
74^th	PYC Therapeutics	$22.06m
75^th	BNK Banking Corporation	$21.59m
76^th	Pentanet	$21.44m
77^th	DW8	$19.88m
78^th	Swift Networks Group	$19.63m

194 public companies - industrial WA ranked by total revenue

View Full List

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
145^th	Macro Metals">Macro Metals	99.43%	-27.89%
146^th	JB Hi-Fi">JB Hi-Fi	99.28%	26.71%
147^th	PYC Therapeutics">PYC Therapeutics	99.15%	26.16%
148^th	Kelly Partners Group Holdings">Kelly Partners Group Holdings	97.11%	61.28%
149^th	Fonterra Shareholders' Fund">Fonterra Shareholders' Fund	95.77%	12.64%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

	NEWS: Tagged in Research a driver for cannabis	15 Dec 2020
	NEWS: Tagged in Phylogica appoints chief scientist as new CEO	15 Dec 2020
	NEWS: Tagged in Hopkins chief at Phylogica	15 Dec 2020
	NEW ROLE: Chief Executive, AusCann Group Holdings	05 Aug 2020

News Articles

Friday, 19 July, 2013 - 11:39
Phylogica appoints chief scientist as new CEO
Perth-based biotechnology company Phylogica has appointed Richard Hopkins chief executive officer as part of wider management changes aimed at pursuing work opportunities with other research companies.
Wednesday, 24 July, 2013 - 10:06
Hopkins chief at Phylogica
Phylogica chief scientist Richard Hopkins has been appointed as chief executive officer and a board member, switching roles with Paul Watt.
Wednesday, 25 July, 2018 - 17:10
Board Moves July 25, 2018
Chris MacKenzie has been appointed chief executive of Manas Resources. Mr MacKenzie, a Chartered Geologist, is an experienced mining executive with over 25 years of industry experience across a number of mineral commodities from target generation and exploration to mining.
Wednesday, 5 August, 2020 - 17:41
Board Moves August 5, 2020
Our board moves wrap includes Nick Woolf, Ido Kanyon, David Round, Simon Storm, Greg Smith, Keith Smith, James Henderson, Francis Harper, Zane Lewis, and Evan Cranston.
Loading
Tuesday, 15 December, 2020 - 08:00
Research a driver for cannabis
The strong growth of the medicinal cannabis industry will need to be supported by research for the sector to take the next step.

Hopkins chief at Phylogica
Wednesday, 24 July, 2013 - 10:06

Board Moves August 5, 2020
Wednesday, 5 August, 2020 - 17:41
TimelineJS
Phylogica appoints chief scientist as new CEO
Hopkins chief at Phylogica
Board Moves July 25, 2018
Board Moves August 5, 2020
Research a driver for cannabis
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.
Nov.
Dec.
Feb.
March
April
May
June
July
Aug.
Sept.
Oct.

Related Information

Positions - Previous

Scroll sideways

Position	Company	Year	Company's current rank
Chief Executive	AusCann Group Holdings	2020 - 2021	154
Chief Business Officer	Arovella Therapeutics	2013 - 2018
Non-Executive Director	PYC Therapeutics	2010 - 2013	74
Senior Biotech Analyst (London)	Nomura	1995 - 1997

Directors Interest

Scroll sideways

Company	Date	Transaction type	Number of shares	Price per share	Transaction value	Nature of change
PYC Therapeutics	2012-04-04	Bought	6,000,000	$0.00		Other
PYC Therapeutics	2012-01-12	Bought	250,000	$0.04	$9,775	On-market trade
PYC Therapeutics	2011-05-16	Bought	847,456	$0.06	$50,000	Other
PYC Therapeutics	2010-10-04	Bought	300,000	$0.05	$14,850	On-market trade
PYC Therapeutics	2010-09-22	Bought	300,000	$0.05	$14,910	On-market trade

Explore Full List

Nick Woolf

Lists and Charts

Revenue

Revenue

Total Shareholder Return as at 02/12/24

Total Shareholder Return as at 02/12/24

Share Transactions

Share Transactions

Person Activity

Friday, 19 July, 2013 - 11:39

Phylogica appoints chief scientist as new CEO

Wednesday, 24 July, 2013 - 10:06

Hopkins chief at Phylogica

Wednesday, 25 July, 2018 - 17:10

Board Moves July 25, 2018

Wednesday, 5 August, 2020 - 17:41

Board Moves August 5, 2020

Tuesday, 15 December, 2020 - 08:00

Research a driver for cannabis

Phylogica appoints chief scientist as new CEO

Hopkins chief at Phylogica

Board Moves July 25, 2018

Board Moves August 5, 2020

Research a driver for cannabis

Related Information

Positions - Previous